The AMDS Hybrid Prosthesis was designed to help clinicians treat DeBakey Type 1 dissections complicated by malperfusion. It works as a complement to hemiarch replacement, preserving the native arch and making reinterventions possible if needed. 

The recall includes a total of nearly 45,000 devices that should be returned to the manufacturer.

These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 

AI impacts care in so many ways now that it often goes unnoticed by clinicians. 

Philippe Généreux, MD, presented updated findings from one of cardiology's most closely watched trials at New York Valves 2026. 

Specific lots of several procedure kits have been recalled after the FDA identified quality issues during a recent inspection.

Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease. 

All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.

No drugs are currently approved by the FDA for the treatment of symptomatic, nonobstructive HCM. Could oral therapy ninerafaxstat be the first?

Treating certain high-risk PCI patients with nicorandil before and after treatment can significantly reduce their risk of contrast-related injuries.